318 related articles for article (PubMed ID: 7484585)
21. Lipid-poor adenomas on unenhanced CT: does histogram analysis increase sensitivity compared with a mean attenuation threshold?
Ho LM; Paulson EK; Brady MJ; Wong TZ; Schindera ST
AJR Am J Roentgenol; 2008 Jul; 191(1):234-8. PubMed ID: 18562751
[TBL] [Abstract][Full Text] [Related]
22. Comparison of CT histogram analysis and chemical shift MRI in the characterization of indeterminate adrenal nodules.
Jhaveri KS; Wong F; Ghai S; Haider MA
AJR Am J Roentgenol; 2006 Nov; 187(5):1303-8. PubMed ID: 17056920
[TBL] [Abstract][Full Text] [Related]
23. [Adrenal incidentalomas: etiologic diagnostics and basic therapeutic management. A mini-review].
Alberti C
G Chir; 2009 May; 30(5):243-50. PubMed ID: 19505420
[TBL] [Abstract][Full Text] [Related]
24. Changing role of imaging-guided percutaneous biopsy of adrenal masses: evaluation of 50 adrenal biopsies.
Paulsen SD; Nghiem HV; Korobkin M; Caoili EM; Higgins EJ
AJR Am J Roentgenol; 2004 Apr; 182(4):1033-7. PubMed ID: 15039183
[TBL] [Abstract][Full Text] [Related]
25. Adrenal adenoma and metastasis from clear cell renal cell carcinoma: can they be differentiated using standard MR techniques?
Woo S; Cho JY; Kim SY; Kim SH
Acta Radiol; 2014 Nov; 55(9):1120-8. PubMed ID: 24252816
[TBL] [Abstract][Full Text] [Related]
26. Value of chemical shift subtraction MRI in characterization of adrenal masses.
Savci G; Yazici Z; Sahin N; Akgöz S; Tuncel E
AJR Am J Roentgenol; 2006 Jan; 186(1):130-5. PubMed ID: 16357391
[TBL] [Abstract][Full Text] [Related]
27. Characterization of adrenal tumors by chemical shift fast low-angle shot MR imaging: comparison of four methods of quantitative evaluation.
Fujiyoshi F; Nakajo M; Fukukura Y; Tsuchimochi S
AJR Am J Roentgenol; 2003 Jun; 180(6):1649-57. PubMed ID: 12760936
[TBL] [Abstract][Full Text] [Related]
28. Histogram analysis for characterization of indeterminate adrenal nodules on noncontrast CT.
Lin MF; Chang-Sen LQ; Heiken JP; Pilgram TK; Bae KT
Abdom Imaging; 2015 Aug; 40(6):1666-74. PubMed ID: 25488345
[TBL] [Abstract][Full Text] [Related]
29. Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT.
Peña CS; Boland GW; Hahn PF; Lee MJ; Mueller PR
Radiology; 2000 Dec; 217(3):798-802. PubMed ID: 11110946
[TBL] [Abstract][Full Text] [Related]
30. Low yield of chemical shift MRI for characterization of adrenal lesions with high attenuation density on unenhanced CT.
Sebro R; Aslam R; Muglia VF; Wang ZJ; Westphalen AC
Abdom Imaging; 2015 Feb; 40(2):318-26. PubMed ID: 25095753
[TBL] [Abstract][Full Text] [Related]
31. Magnetic resonance imaging of the adrenal gland.
Boland GW; Lee MJ
Crit Rev Diagn Imaging; 1995; 36(2):115-74. PubMed ID: 7612177
[TBL] [Abstract][Full Text] [Related]
32. Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role?
Haider MA; Ghai S; Jhaveri K; Lockwood G
Radiology; 2004 Jun; 231(3):711-6. PubMed ID: 15118113
[TBL] [Abstract][Full Text] [Related]
33. Adrenal adenomas: characteristic hyperintense rim sign on fat-saturated spin-echo MR images.
Ichikawa T; Ohtomo K; Uchiyama G; Koizumi K; Monzawa S; Oba H; Nogata Y; Kachi K; Toyama K; Yamaguchi M
Radiology; 1994 Oct; 193(1):247-50. PubMed ID: 8090900
[TBL] [Abstract][Full Text] [Related]
34. Dual-energy CT for characterization of adrenal nodules: initial experience.
Gupta RT; Ho LM; Marin D; Boll DT; Barnhart HX; Nelson RC
AJR Am J Roentgenol; 2010 Jun; 194(6):1479-83. PubMed ID: 20489086
[TBL] [Abstract][Full Text] [Related]
35. [Update in adrenal imaging].
Tenenbaum F; Lataud M; Groussin L
Presse Med; 2014 Apr; 43(4 Pt 1):410-9. PubMed ID: 24636681
[TBL] [Abstract][Full Text] [Related]
36. Differentiation of adrenal tumors in patients with hepatocellular carcinoma: adrenal adenoma versus metastasis.
Yasaka K; Gonoi W; Akai H; Katsura M; Akahane M; Kiryu S; Ohtomo K
Eur J Radiol; 2013 Aug; 82(8):1213-8. PubMed ID: 23478006
[TBL] [Abstract][Full Text] [Related]
37. Is computed tomography guided biopsy still necessary for the diagnosis of adrenal masses in patients with resectable non-small-cell lung cancer?
Porte HL; Ernst OJ; Delebecq T; Métois D; Lemaitre LG; Wurtz AJ
Eur J Cardiothorac Surg; 1999 May; 15(5):597-601. PubMed ID: 10386403
[TBL] [Abstract][Full Text] [Related]
38. Determination of a cutoff attenuation value on single-phase contrast-enhanced CT for characterizing adrenal nodules via chemical shift MRI.
Wu YW; Tan CH
Abdom Radiol (NY); 2016 Jun; 41(6):1170-7. PubMed ID: 26830419
[TBL] [Abstract][Full Text] [Related]
39. Contrast-enhanced sonography of adrenal masses: differentiation of adenomas and nonadenomatous lesions.
Friedrich-Rust M; Schneider G; Bohle RM; Herrmann E; Sarrazin C; Zeuzem S; Bojunga J
AJR Am J Roentgenol; 2008 Dec; 191(6):1852-60. PubMed ID: 19020259
[TBL] [Abstract][Full Text] [Related]
40. Adrenal masses in patients with malignancy: prospective comparison of echo-planar, fast spin-echo, and chemical shift MR imaging.
Schwartz LH; Panicek DM; Koutcher JA; Brown KT; Getrajdman GI; Heelan RT; Burt M
Radiology; 1995 Nov; 197(2):421-5. PubMed ID: 7480686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
